MILBURN, NJ -- (BUSINESS WIRE) -- The Zitter Group, a market-leading healthcare research firm that assists life science companies with issues related to product access, reimbursement, and managed markets, has rebranded itself as Zitter Health Insights.
Founded in 1989, the company initially produced conferences and conducted custom research with a variety of stakeholders on managed care trends during the time when payer impact increased dramatically. The company developed the nation’s largest payer research panel that consistently generates responses from more than 100 payers –critical for statistically significant results -- and created the nation’s largest database of prior authorization policies. As the managed markets landscape became more complex, the company began to offer insights in multi-client subscription formats. “Access Answered” is the tagline corresponding with the name change, reflecting the definitive source for answers to all questions related to product access.
“Our mission is to provide unparalleled insight into the ways that payers are influencing the use of life sciences products,” said Mark Zitter, CEO. “Our new brand more accurately reflects our mission and value offering of providing innovative relevant research products that reflect the business practices and perspectives of managed care organizations. The brand also includes our expanding focus encompassing payer influence on employers, consumers, retail and specialty pharmacies, physicians, practice managers and other key individuals and organizations.”
Pharmaceutical and biotech marketers use the insights to help with forecasting, course correction, co-pay program planning, competitive counter-detailing, contracting, and more. Managed care organizations use the services to benchmark their efforts. To see the new brand and learn more about specific products, visit www.zitter.com.
About Zitter Health Insights
Zitter Health Insights is a market-leading healthcare research firm that assists life science companies with issues related to product access, reimbursement, and managed markets. The company developed the nation’s largest payer research panel and the nation’s largest database of prior authorization policies. The average panel member represents 1 million+ covered lives and the research portfolio covers the entire spectrum of payer-influenced entities. Insights are generated primarily in multi-client subscription formats including: Managed Care Oncology Index, Managed Care Biologics and Injectables Index, Managed Care Benefit Design Index, Prior Authorization Tracking Tool, Managed Care Message Monitor, Co-Pay Offset Monitor, and P&T Perspective. Analysis is conducted for more than 250 manufacturers, 150 therapeutic areas and 1,000 products.